Compare AMT & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMT | BSX |
|---|---|---|
| Founded | 1995 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4B | 93.4B |
| IPO Year | 1998 | 2010 |
| Metric | AMT | BSX |
|---|---|---|
| Price | $183.47 | $57.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 22 |
| Target Price | ★ $222.38 | $93.18 |
| AVG Volume (30 Days) | 2.6M | ★ 16.8M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | ★ 4.02% | N/A |
| EPS Growth | 12.03 | ★ 55.20 |
| EPS | ★ 1.84 | 0.90 |
| Revenue | ★ $10,644,600,000.00 | $9,076,000,000.00 |
| Revenue This Year | $2.41 | $11.85 |
| Revenue Next Year | $3.42 | $10.16 |
| P/E Ratio | $99.67 | ★ $63.33 |
| Revenue Growth | 5.11 | ★ 12.49 |
| 52 Week Low | $165.08 | $52.52 |
| 52 Week High | $234.33 | $109.50 |
| Indicator | AMT | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 48.54 |
| Support Level | $181.84 | $52.52 |
| Resistance Level | $196.60 | $58.18 |
| Average True Range (ATR) | 4.36 | 1.55 |
| MACD | 0.81 | 0.72 |
| Stochastic Oscillator | 90.56 | 84.56 |
American Tower owns and operates about 150,000 wireless towers throughout the US, Asia, Latin America, Europe, and Africa. It also owns and/or operates 30 data centers in 11 US markets after acquiring CoreSite. The company's customer base in the tower business is very concentrated, with most revenue in each market generated by the top three or four mobile carriers. The company operates more than 40,000 towers in the US, which accounted for about half of total revenue in 2025. Outside the US, American Tower operates about 47,000 towers in Latin America (dominated by Brazil), 33,000 towers in Europe, and 28,000 towers in Africa. American Tower operates as a REIT.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.